Wednesday, June 3, 2015

10 Best Income Stocks To Own Right Now

Source: Texas Roadhouse.

Texas Roadhouse (NASDAQ: TXRH  ) is hoping that it's not just its signature steaks that are meaty. The chain of 436 casual steakhouses posted quarterly results after Monday's market close.

Revenue climbed 15% to $385.2 million as new openings and a 5.9% uptick in comps combined to drive the top line higher. Net income climbed 10% to $18.9 million, or $0.27 a share.�

It was a mixed showing relative to Wall Street expectations. Analysts were holding out for a profit of $0.29 a share, but they were also only settling for $375.9 million in revenue.�

The stock initially ticked higher in after-hours trading on Monday, suggesting that the tug-of-war between bulls pulling on the top-line beat and bears tugging on the bottom-line miss is being won by the longs.

It also helps that Texas Roadhouse offered up a couple of legitimate reasons for the failure of earnings to grow as quickly as revenue. Food costs rose and general liability insurance clocked in higher as a result of an overlapping credit a year earlier. Its income tax rate bumped higher, given the expiration of a work opportunity tax credit last year and higher stock option exercise activity last year. The income tax disparity alone took a 12% uptick in operating profit down to the ultimate 10% bottom-line gain.

5 Best Rising Stocks To Watch Right Now: Grupo Casa Saba S.A. de C.V.(SAB)

Grupo Casa Saba, S.A.B. de C.V., through its subsidiaries, operates as a multi-channel and multi-product wholesale distributor primarily in Mexico. It distributes pharmaceutical products; health and beauty aids; publication products, such as magazines, books, albums, and stickers; food and non-perishable products; personal care and consumer goods; and general merchandise. The company also sells pharmaceutical products through its Farmacias ABC pharmacy chain located in Guadalajara, Jalisco; Farmacias Provee de Especialidades primarily located in Monterrey and Nuevo Leon of Mexico, as well as in the states of Chihuahua and Coahuila; and through Farmacias Benavides. In addition, it provides freight services to third parties. Further, it operates medical clinics; and offers specialized medical, rehabilitation, and surgical services, as well as provides real estate services. The company serves pharmacies, mass merchandisers, retail and convenience stores, specialty stores, sup ermarkets, and other specialized channels. As of December 31, 2010, it operated a distribution network consisting of 22 active distribution centers. It also operates in Brazil, Chile, and Peru. Grupo Casa Saba, S.A.B. de C.V. was founded in 1892 and is based in Mexico, Mexico.

Advisors' Opinion:
  • [By Tom Stoukas]

    SABMiller Plc (SAB) lost 2.1 percent to 3,462 pence. The world�� second-largest brewer said earnings before interest, taxes and amortization in the year to March 31 rose to $6.42 billion. That missed the median estimate of 13 analysts in a Bloomberg News survey that called for $6.46 billion.

  • [By Inyoung Hwang]

    U.K. stocks erased losses in the last half hour of trading, leaving the FTSE 100 Index (UKX) little changed, as a rally in British Sky Broadcasting Group Plc (BSY) and SABMiller Plc (SAB) offset Dagong Global Credit Rating Co.�� downgrade of U.S. sovereign debt.

  • [By Dividend Mantra]

    Altria Group, Inc. operates as a holding company with a number of subsidiaries, including Philip Morris USA Inc., U.S. Smokeless Tobacco Company LLC, John Middleton Co., Ste. Michelle Wine Estates Ltd. and Philip Morris Capital Corporation. They also hold approximately 26.9% of the economic and voting rights of SABMiller plc (SAB).

10 Best Income Stocks To Own Right Now: Student Transportation Inc (STB)

Student Transportation Inc. (STI) is a provider of school bus transportation services in North America, conducting operations through wholly owned operating subsidiaries. The Company operates in two segments: a transportation segment and an oil and gas segment. The transportation segment provides school bus and management services to public and private schools in North America. The oil and gas segment represents its investments as a non-operator in oil and gas interests. During the fiscal year ended June 30, 2012 (fiscal 2012), it acquired certain assets of Schumacher Bus Lines; certain assets and contracts of S&K Transportation Inc.; A&B Bus, Co.; School Transportation Services, LLC.; Dairyland Bus, Inc., Dairyland-Hamilton, Inc., Lakeland Area Bus Service, Inc. and Lakeside Buses of Wisconsin, Inc., and certain assets and contracts of Safe Start Transportation of New Jersey, LLC. On May 24, 2012, the Company acquired certain assets and contracts of National Express Corporation. Advisors' Opinion:
  • [By Charles Sizemore]

    Finally, for an off-the-wall pick, consider picking up shares of Student Transportation (STB), North America�� third-largest operator of school buses.� Student Transportation doesn’t just operate more than 10,000 school buses and transport more than a million students daily across the United States and Canada. It’s a monthly dividend stock with a solid yield.

10 Best Income Stocks To Own Right Now: CirTran Corp (CIRC)

CirTran Corporation, incorporated on March 23, 1987, manufactures, markets, and distributes internationally an energy drink under a license with Playboy Enterprises, Inc. (Playboy) through its subsidiary, CirTran Beverage Corporation. It operates in Beverage Distribution and Contract Manufacturing segments. In the United States, it provides a mix of high- and medium-volume turnkey manufacturing services and products using various high-tech applications for electronics original equipment manufacturers (OEMs) in the communications, networking, peripherals, gaming, law enforcement, consumer products, telecommunications, automotive, medical, and semiconductor industries. The Company�� services include pre-manufacturing, manufacturing, and post-manufacturing services.

Beverage Distribution

CirTran Beverage Corporation (CirTran Beverage) manufactures, markets, and distributes Playboy-licensed energy drinks, flavored water beverages, and related merchandise through various distribution channels. As of December 31, 2012, the Company had 65 countries throughout Europe, Africa, Australia, the Pacific, and the Middle East.

Contract Marketing

CirTran Products Corp. pursues contract-manufacturing relationships in the domestic consumer products markets, including products in areas, such as home/garden, kitchen, health/beauty, toys, licensed merchandise, and apparel for film, television, sports, and other entertainment properties. The Company concentrates its product development efforts into three areas: home and kitchen appliances, beauty products, and licensed merchandise. Through CirTran - Asia, Inc., the Company designs, manufactures, and supplies products in the international electronics, consumer products, and general merchandise industries for various marketers, distributors, and retailers selling overseas. This subsidiary provides manufacturing services to the direct-response and retail consumer markets.

The Company competes with Hansen�! � Energy, Diet Red, Monster Energy, Lost Energy, Joker Mad Energy, Ace Energy, Unbound Energy, Rumba energy juice, Red Bull, Rockstar, Full Throttle, No Fear, Amp, Adrenaline Rush, 180, Extreme Energy Shot, Red Devil, Rip It, NOS, Boo Koo, and Vitaminenergy.

Advisors' Opinion:
  • [By CRWE]

    Last Friday, CIRC remained (0.00%) +0.000 at $.0005 at the close (ref. google finance August 30, 2013 ��Close).

    CirTran Corporation has recently filed its Quarterly Report on Form 10-Q for the period ended June 30, 2013, showing continued growth in sales and a dramatic improvement in profits. CirTran�� sales were again driven by its Playboy Energy Drink line, which has grown to represent nearly 98% of revenues.

    For the quarter, CirTran previously reported sales of $1,096,691, a 247% increase over the $315,755 reported for the same period a year ago. For the six months ended June 30, 2013, CirTran reported sales of 1,964,843, a 110% improvement over the $934,455 reported for the first half of 2012.

10 Best Income Stocks To Own Right Now: Regulus Therapeutics Inc (RGLS)

Regulus Therapeutics Inc., incorporated on September 5, 2007, is a biopharmaceutical company focused on discovering and developing microRNAs to treat a range of diseases. microRNAs are naturally occurring ribonucleic acid (RNA), molecules that play a critical role in regulating key biological pathways. The Company uses its microRNA product platform to develop chemically modified, single-stranded oligonucleotides that the Company calls anti-miRs. As of December 31, 2012, the Company�� operations included acquiring and in-licensing intellectual property rights, developing its microRNA, undertaking basic research around microRNA targets and conducting preclinical studies for its initial programs.

The Company is developing RG-101 for the treatment of HCV and is advancing other microRNA therapeutics toward clinical development in several areas, including oncology, fibrosis and metabolic diseases. The Company intends to focus its resources on product opportunities in therapeutic areas where development and commercialization activities are appropriate for its size and financial resources, which the Company anticipates will include niche indications and orphan diseases.

The Company competes with Groove Biopharma, Inc., miRagen Therapeutics, Inc., Mirna Therapeutics, Inc., and Santaris Pharma A/S.

Advisors' Opinion:
  • [By Sean Williams]

    A blast to the past
    It's occasionally very difficult to value biotech stocks, because of the wide range of outcomes possible given their pipelines. Other times, as in the case with Regulus Pharmaceuticals (NASDAQ: RGLS  ) , I bang my head against a table and wonder what the heck investors are thinking.

10 Best Income Stocks To Own Right Now: Maximus Inc (MMS)

MAXIMUS, Inc., incorporated on October 18, 2007, provides business process services (BPS) to government health and human services agencies under its mission of Helping Government Serve the People. The Company is primarily focused on operating government-sponsored programs, such as Medicaid, Children's Health Insurance Program (CHIP), health insurance exchanges and other health care reform initiatives, Medicare, welfare-to-work, child support services and other government programs.

The Company is one of the pure-play health and human services administrative providers to governments in the United States, Australia, Canada, the United Kingdom and Saudi Arabia. The Company�� segments include Health Services and Human Services. Effective July 1, 2013, MAXIMUS, Inc. acquired Health Management Ltd.

Health Services Segment

The Company's Health Services segment provides a variety of business process services, as well as related consulting services, for state, provincial and federal government programs, including Medicaid, CHIP, SNAP (Supplemental Nutrition Assistance Program), Medicare, the Affordable Care Act and Health Insurance BC (British Columbia). In this segment, the Company's BPS and consulting services include government health insurance program administration; Health insurance program eligibility and enrollment services to improve access to health care for citizens and help beneficiaries make the best choice for their health insurance coverage; Eligibility and enrollment modernization for government health benefit programs; Health insurance exchange design and operations; Consumer outreach and education, including multilingual customer contact centers and multi-channel self-service options, such as Web-based portals, for easy enrollment; Application assistance and independent enrollment counseling to beneficiaries; Premium payment processing and administration, such as invoicing and reconciliation; Objective, evidence-based health appeals; Independent medical! reviews; Health plan oversight; eHealth solutions with the Medigent product suite; Medicaid Management Information System (MMIS) planning and oversight, and Specialized program consulting services.

Human Services Segment

The Company's Human Services segment provides federal, national, state and county human services agencies with a variety of business process services, as well as related consulting services for welfare-to-work, child support, higher education and K-12 special education programs. The Company's services include welfare-to-work services, including eligibility determination, case management, job-readiness preparation, job search and employer outreach, job retention and career advancement, and selected educational and training services, to help disadvantaged individuals transition from government assistance programs to sustainable employment and economic independence; Full and specialized child support case management services, customer contact center operations, and program and systems consulting services; Management tools and professional consulting services for higher education institutions; K-12 special education case management solutions; Program consulting services, including independent verification and validation, cost allocation plans, repeatable management services and other specialized consulting offerings, and Tax credit and employer services.

The Company competes with Serco, Atos Origin and Ingeus.

Advisors' Opinion:
  • [By Michael Flannelly]

    Analysts at Jefferies initiated coverage on business process services provider Maximus Inc. (MMS) late on Thursday, giving the stock a bullish rating because it has several competitive advantages and should benefit from the Affordable Care Act (Obamacare).

    The analysts rate MMS as “Buy” and see shares reaching $47. This price target suggests a 20% upside to the stock’s Thursday closing price of $39.14.

    “MMS is a leading government outsourced contractor that produces consistently strong results,” Jefferies analyst David Styblo commented. “The company has several competitive advantages and is highly focused on health and human service projects. This positions MMS to enjoy multi-year growth from the ACA and other opportunities with limited risk. The company’s predictable business model, solid balance sheet, and EPS visibility into FY2014 also support a Buy and $47 PT.”

    Maximus shares were inactive during pre-market trading on Friday. The stock is up 23.83% year-to-date.

  • [By Laura Brodbeck]

    Tuesday

    Earnings Expected From: Five Star Quality Care, Inc. (NYSE: FVE), Maximus, Inc. (NYSE: MMS), Nustar Energy (NYSE: NS), D.R. Horton, Inc. (NYSE: DHI), DISH Network Corporation (NASDAQ: DISH) Economic Releases Expected: German CPI, British CPI, British PPI, US Redbook, Indian manufacturing output, Indian industrial production

    Wednesday

  • [By Ben Levisohn]

    Shares of Iron Mountain have fallen 2.3% to $25.72 today, while comparable have been mixed. Leidos Holdings (LDOS) has ticked up 0.6% to $46.28 and Amdocs (DOX) has risen 0.8% to $37.20. Maximus (MMS), on the other hand, has fallen 1.2% to $46.22 and Xerox (XRX) is off 0.3% to $10.62.

  • [By Hilary Kramer]

    This is where one of my favorite plays on the healthcare reform comes in. Maximus (MMS) provides cost-effective processing services to government health and human services agencies in the United States, Canada, United Kingdom, Australia and Saudi Arabia. One of its main focuses is healthcare, providing administrative services for many programs, including Medicaid, Children’s Health Insurance Program (CHIP) and Medicare.

10 Best Income Stocks To Own Right Now: Andatee China Marine Fuel Services Corporation(AMCF)

Andatee China Marine Fuel Services Corporation, through its subsidiaries, engages in the production, storage, distribution, and wholesale purchase, and sale of blended marine fuel oil for cargo and fishing vessels primarily in Tianjin City, and Liaoning, Shandong, and Zhejiang Provinces in the People?s Republic of China. It sells its products through distributors, as well as to retail customers. The company was founded in 1997 and is based in Dalian, the People?s Republic of China.

Advisors' Opinion:
  • [By Roberto Pedone]

    Another under-$10 energy player that's starting to move within range of triggering a big breakout trade is Andatee China Marine Fuel Services (AMCF), which is engaged in the production, storage, distribution and wholesale purchases and sales of blended marine fuel oil for cargo and fishing vessels. This stock has been in play with the bulls so far in 2013, with shares up big by 180%.

    If you take a look at the chart for Andatee China Marine Fuel Services, you'll notice that this stock has been uptrending strong over the last month and change, with shares moving higher from its low of 98 cents per share to its recent high of $1.69 a share. During that move, shares of AMCF have been making mostly higher lows and higher highs, which is bullish technical price action. That move is now starting to push shares of AMCF within range of triggering a big breakout trade above a key downtrend line.

    Market players should now look for long-biased trades in AMCF if it manages to break out above some near-term overhead resistance levels at $1.69 to $1.80 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 215,352 shares. If that breakout hits soon, then AMCF will set up to re-test or possibly take out its next major overhead resistance levels at $1.98 to just above $2.20 a share. Any high-volume move above those levels will then give AMCF a chance to tag its 52-week high at $2.75 a share.

    Traders can look to buy AMCF off any weakness to anticipate that breakout and simply use a stop that sits right around some key near-term support levels at $1.29 or at $1.15 a share. One can also buy AMCF off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

10 Best Income Stocks To Own Right Now: Insmed Inc.(INSM)

Insmed Incorporated, a biopharmaceutical company, focuses on the development of inhaled pharmaceuticals for the site-specific treatment of serious lung diseases. The company primarily focuses on the development of inhaled antibiotic therapy delivered via proprietary advanced pulmonary liposome technology in areas of high unmet need in lung diseases. Its lead product candidate includes ARIKACE, an inhaled antibiotic supported by positive phase 2 results for treating serious lung infections due to susceptible bacteria. The U.S. Food and Drug Administration has cleared the company's investigational new drug application to conduct a pivotal Phase 3 clinical trial of ARIKACE in nontuberculous mycobacteria lung infections. Insmed Incorporated was founded in 1999 and is based in Monmouth Junction, New Jersey.

Advisors' Opinion:
  • [By Sean Williams]

    The bad
    Don't say I didn't tell you so, but Insmed (NASDAQ: INSM  ) shares sank like a stone after reporting late-stage results for Arikace, its experimental treatment for non-tuberculosis mycobacterial lung infections. Although Arikace met its primary endpoint of being non-inferior to the current standard of treatment, TOBI, which is made by Novartis, the results didn't exactly wow analysts who now see limited upside even if it's approved by the FDA. Simply put, without any measurable differentiation, Insmed could have a hard time gaining sales traction and is still quite the long shot to be profitable.

  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    Monday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Nordion (NYSE: NDZ) and Insmed (NASDAQ: INSM).

  • [By Brian Pacampara]

    Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biopharmaceutical company Insmed (NASDAQ: INSM  ) has received a distressing two-star ranking.

No comments:

Post a Comment